Cervical Screening: UK Rates & Risks
- A meaningful portion of the UK population is behind on thier cervical cancer screening, and disparities in HPV vaccine uptake across England may heighten the risk for some,...
- Data from NHS England indicates a drop in cervical screening attendance, from 72.2% in 2020 to 68.4% in 2024.
- A Cancer Research UK-commissioned YouGov survey found that 30% of 3,000 respondents eligible for cervical cancer screening were overdue.
UK cervical cancer screening rates are currently declining, with approximately a third of eligible women overdue for their screenings. This highlights an urgent need to address teh situation. The HPV vaccine’s uptake shows considerable regional discrepancy. Regular cervical cancer screening using the HPV test and the Pap test remains critical for early detection because cervical cancer develops over time. News Directory 3 provides this critical information, with data from NHS England showing a drop in screening attendance. Discover the barriers to cervical cancer screening identified in a recent study,wich include past painful experiences and a lack of information. Learn how to stay informed about safeguarding female health through regular screenings. Discover what’s next …
Cervical Cancer Screening Rates decline in UK; HPV Vaccine Uptake Varies
Updated June 20, 2025
A meaningful portion of the UK population is behind on thier cervical cancer screening, and disparities in HPV vaccine uptake across England may heighten the risk for some, health experts caution.The screening program plays a crucial role in early detection and prevention.
Data from NHS England indicates a drop in cervical screening attendance, from 72.2% in 2020 to 68.4% in 2024. This decline highlights the importance of understanding the role of regular screenings.
A Cancer Research UK-commissioned YouGov survey found that 30% of 3,000 respondents eligible for cervical cancer screening were overdue. The survey also revealed barriers to screening, including past painful experiences (42%), preference for a female provider (40%), and embarrassment (19%).
Notably, 16% of non-attendees believed screening was unnecessary due to the absence of symptoms, underscoring the need for public education about the preventative role of screening.
figures from the UK Health security Agency (UKHSA) show significant regional variation in HPV vaccine uptake. Year 10 girls in London have the lowest uptake (64.9%), while those in the southeast have the highest (82.7%). Similar trends exist among boys, with London at 58.9% and the southeast at 77.3%.
HPV, a group of sexually transmitted viruses, includes about 13 high-risk types responsible for nearly all cervical cancers.